Drug delivery devices for retinal diseases

Research output: Contribution to journalReview articlepeer-review

25 Citations (Scopus)

Abstract

Retinal degenerative diseases are a leading cause of irreversible blindness and visual impairment, affecting millions of people worldwide. Although intravitreal injection can directly deliver drugs to the posterior segment of the eye, it is invasive and associated with serious side effects. The design of drug delivery systems targeting the posterior segment of the eye in a less invasive manner has still been challenging because of various anatomical and physiological barriers. In this review, we provide an overview of the current implant device-based approaches used for treating retinal degenerative diseases. We then offer our perspectives on future directions and challenges that remain for developing more effective device-based therapies for retinal diseases.

Original languageEnglish
Pages (from-to)148-157
Number of pages10
JournalAdvanced Drug Delivery Reviews
Volume128
DOIs
Publication statusPublished - 2018 Mar 15

Keywords

  • Biodegradable
  • Intraocular implants
  • Non-biodegradable
  • Periocular implants
  • Posterior segment of the eye
  • Transscleral route

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Drug delivery devices for retinal diseases'. Together they form a unique fingerprint.

Cite this